PPT-Management of atrial fibrillation

Mary N Healy MS ARNPBC Heart amp Vascular Center of Sarasota OBJECTIVES Define the difference between paroxysmal and persistent Atrial Fibrillation State the CVA risk per year of a 68 yr. The LAA is a normal part of the heart anatomy and causes no problems in the general population However this pouch is a major source of blood clots in patients with atrial fibrillation Atrial fibrillation AF is the biggest risk factor for blood clots  MANAGING ATRIAL FIBRILLATION (AF) (MODULE 2) MODULE 2: MANAGING ATRIAL FIBRILLATION ii \r\f\n \t\b
\n\b\t A U G U S T 2 0 1 4. Physicians. 2. Physicians. A majority of physicians believe most Atrial Fibrillation patients don’t usually understand their increased risk of stroke and feel most patients underestimate the impact ischemic stroke can have on their lives. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . www.RxFiles.ca June 2021 Drug / BRAND Vitamin K Antagonist DOACs Comments There is a positive correlation between warfarin Carlos Calle-Muller, MD. Cardiac Electrophysiology. 734-855-9448. Objectives. To recognize the risks for patients with atrial fibrillation. To familiarize with the management of atrial fibrillation. Atrial fibrillation (AF) is the most common cardiac arrhythmia . Amir Shaikh, MD; David D McManus, . MD,ScM. Assistant Professor,. Department of Medicine. University of Massachusetts Medical School, Worcester, MA, USA. Disclosures. David D McManus, MD, . ScM. has received research funding from: . Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH. David MacLennan. NHS Lothian/Fife. South East Scotland Deanery. Freedom . from atrial fibrillation at 12 . months: 63. % of the mitral valve surgery plus ablation group . vs. . 29% of the mitral valve surgery alone group (p < . 0.001). Among . the ablation group, freedom from atrial fibrillation occurred in 61% with PVI vs. 66% with . HEARTSERIESH9 Theinformationcontainedinthisbookletisbasedonguidelinesandpracticeand iscorrectattimeofprinting.Thecontenthasundergonepee,patientandexpertrevie. Theinformationcontainedinthisbookletisba